Bevacizumab 2 — Class II drug recall D-1308-2019
Terminated recall by Avella of Deer Valley, Inc. Store 38, reported 2019-06-05, distributed nationwide. Lack of assurance of sterility
| Recall number | D-1308-2019 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Avella of Deer Valley, Inc. Store 38, Phoenix, AZ, United States |
| Recall initiated | 2019-05-03 |
| Classified | 2019-05-29 |
| Reported by FDA | 2019-06-05 |
| Terminated | 2020-02-25 |
| Distributed | Nationwide (US) |
| Quantity | 730 syringes |
| Reason classes | sterility |
| NDC | 42852-0001-27 |
| Expiration dates | 2019-05-13 |
Product
Bevacizumab 2.5 mg/0.1 mL, packaged in a Prefilled Syringe, Rx only, AVELLA SPECIALTY PHARMACY 24416 N. 19TH AVENUE PHOENIX, AZ 85085, NDC 42852-001-27
Reason for recall
Lack of assurance of sterility
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1308-2019. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.